Literature DB >> 9439753

Pathogenesis of thrombosis in coronary artery disease.

J H Chesebro1, U Rauch, V Fuster, J J Badimon.   

Abstract

Arterial thrombosis in the acute coronary syndromes is precipitated by plaque disruption. This occurs in lesions with a large lipid core, a thin fibrous cap, macrophages infiltrating the fibrous cap, and a lipid core with a high tissue-factor content. This results in acute platelet deposition and rapid growth of mural thrombus which unfavorably influences the rheology of blood flow to produce more thrombus, and propagates additional thrombosis by the high thrombogenicity of the mural thrombus overlying the disrupted culprit arterial lesion. Acute therapy in the hospital and subacute therapy beyond the hospital phase for as long as 1.5-3 months with aspirin plus anticoagulation, such as low-molecular-weight heparin, or oral anticoagulation, reduces thrombotic occlusion, myocardial infarction, death, and need for coronary revascularization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9439753     DOI: 10.1159/000217477

Source DB:  PubMed          Journal:  Haemostasis        ISSN: 0301-0147


  5 in total

Review 1.  Inorganic nitrate: a major player in the cardiovascular health benefits of vegetables?

Authors:  Ajay Machha; Alan N Schechter
Journal:  Nutr Rev       Date:  2012-04-19       Impact factor: 7.110

2.  Ambient temperature and emergency room admissions for acute coronary syndrome in Taiwan.

Authors:  Wen-Miin Liang; Wen-Pin Liu; Sze-Yuan Chou; Hsien-Wen Kuo
Journal:  Int J Biometeorol       Date:  2007-10-25       Impact factor: 3.787

3.  Comparison of GP IIB/IIIA inhibitors and their activity as measured by aggregometry, flow cytometry, single platelet counting, and the rapid platelet function analyzer.

Authors:  A C Matzdorff; G Kühnel; B Kemkes-Matthes; R Voss
Journal:  J Thromb Thrombolysis       Date:  2001-10       Impact factor: 2.300

4.  The effect of clopidogrel on platelet activity in patients with and without type-2 diabetes mellitus: a comparative study.

Authors:  Claudia Schuette; Daniel Steffens; Marco Witkowski; Caroline Stellbaum; Peter Bobbert; Heinz-Peter Schultheiss; Ursula Rauch
Journal:  Cardiovasc Diabetol       Date:  2015-02-03       Impact factor: 9.951

5.  Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.

Authors:  Marco Witkowski; Alice Weithauser; Termeh Tabaraie; Daniel Steffens; Nicolle Kränkel; Mario Witkowski; Bernd Stratmann; Diethelm Tschoepe; Ulf Landmesser; Ursula Rauch-Kroehnert
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-04-28       Impact factor: 8.311

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.